Antibiotics API sales will strengthen through 2036, anchored by pharmaceutical companies at 75.9% of end user share in 2026. The industry was valued at USD 9.2 billion in 2025 and is projected to reach USD 12.9 billion by 2036, creating an incremental opportunity of USD 3.4 billion worldwide.